Last week, we asked how aggressive investors should be in pushing a portfolio company to make changes and if there are frequent disagreements.
- Bruce Taragin, managing director at Blumberg Capital, said that disagreements are common but are also expected and healthy. “A leadership team and board that are well-aligned on the company’s priorities may sometimes agree to disagree on the details, but typically agree on how to move forward. Investors should offer guidance and tools to leadership and let them make a decision in the company’s best interest.”
Read the full article here.